BMO Capital Initiates Coverage On Globus Medical with Outperform Rating, Announces Price Target of $94

Benzinga Newsdesk www.benzinga.com Positive 84.6%

Neg 0% Neu 0% Pos 84.6%

BMO Capital initiates coverage on Globus Medical (NYSE:GMED) with a Outperform rating and announces Price Target of $94.